Latest News
Coronavirus Update: Novavax is part of the FDA’s COVID-19 booster debate, but its vaccine still hasn’t been authorized
Novavax’s NVAX, +0.85% COVID-19 vaccine candidate played a front-and-center role during this week’s debate about how best to update the COVID-19 boosters to ...